European Association for the Study of the Liver (EASL)–American Association for the Study of Liver Disease (AASLD) Hepatitis B Virus (HBV) Endpoints

Combining the intellectual might of the largest European and American hepatology societies, the EASL–AASLD HBV Endpoints workshop brings attendees together to discuss the vital details of trial design, therapeutic endpoints, patient populations, and more. With many treatment modalities on offer for hepatitis B, this event offers hepatologists the opportunity to help define the term ‘cure’ when used in the context of this disease.